Q2 2024 Sangamo Therapeutics Inc Earnings Call Transcript
Good afternoon, and welcome to the Sangamo Therapeutics' second-quarter 2024 teleconference call. Please be advised that today's conference is being recorded.
I would now like to turn the conference over to your speaker today, Louise Wilkie, Vice President of Investor Relations and Corporate Communications. Please go ahead.
Thank you. Good afternoon, everyone. Thank you for joining us on the call today. On this call are several members of the Sangamo executive leadership team, including Sandy Macrae, Chief Executive Officer; Prathyusha Duraibabu, Chief Financial Officer; Nathalie Dubois-Stringfellow, Chief Development Officer; Amy Pooler, Head of Research; and Greg Davis, Head of Technology.
Slides from our corporate presentation can be found on our website, sangamo.com, under the Presentations page of the Investors and Media section.
This call includes forward-looking statements regarding Sangamo's current expectations. These statements include, but are not limited to,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |